Ocular Therapeutix, Inc. is a privately held company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology. Ocular Therapeutix is focusing on development of drug-eluting punctum plugs for treatment of glaucoma and post-operative inflammation and pain, injectable depots for back-of-the-eye diseases, and ReSure Sealant for sealing clear corneal incisions following lens implantation surgery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/28/13 | $23,800,000 | Series D-2 |
Ascension Health Ventures Polaris Partners Sparta Versant Ventures | undisclosed |
| 06/10/13 | undisclosed |
Ascension Health Ventures Baxter Ventures | undisclosed |
